Literature DB >> 7611022

CT and MR of the brain in glutaric acidemia type I: a review of 59 published cases and a report of 5 new patients.

J Brismar1, P T Ozand.   

Abstract

PURPOSE: To identify a pattern of findings on CT or MR of the brain in glutaric acidemia type I typical enough to permit a correct diagnosis.
METHODS: Clinical history and findings and brain CT and MR results in 59 previously reported patients (MR in 12) and in 5 new patients (all examined with MR and 3 also with CT) were reviewed.
RESULTS: In half the patients macrocephaly was present, and in half the onset was acute, often following infection and mimicking encephalitis. Although brain atrophy or hypoplasia was found in 61% and white matter changes in 51% of the patients, open opercula (usually very widely open) and often also wide cerebrospinal fluid spaces anterior to the temporal lobes were seen in 93%. Basal ganglia lesions, presenting as volume loss and high T2 signal in the caudate head and often also the lentiform nucleus bilaterally, were found in 44% and extracerebral fluid collections in 7 of 64 patients.
CONCLUSION: The finding of very widely open opercula suggests glutaric acidemia type I, and if combined with basal ganglia lesions is almost pathognomonic, especially in a child with macrocephaly.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7611022      PMCID: PMC8332252     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  38 in total

1.  Adult-onset glutaric aciduria type I presenting with white matter abnormalities and subependymal nodules.

Authors:  T M Pierson; Mani Nezhad; Matthew A Tremblay; Richard Lewis; Derek Wong; Noriko Salamon; Nancy Sicotte
Journal:  Neurogenetics       Date:  2015-08-29       Impact factor: 2.660

Review 2.  Challenges for basic research in glutaryl-CoA dehydrogenase deficiency.

Authors:  S Kölker; K A Strauss; S I Goodman; G F Hoffmann; J G Okun; D M Koeller
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 3.  Emergency treatment in glutaryl-CoA dehydrogenase deficiency.

Authors:  S Kölker; C R Greenberg; M Lindner; E Müller; E R Naughten; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

4.  Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I).

Authors:  S Kölker; E Christensen; J V Leonard; C R Greenberg; A B Burlina; A P Burlina; M Dixon; M Duran; S I Goodman; D M Koeller; E Müller; E R Naughten; E Neumaier-Probst; J G Okun; M Kyllerman; R A Surtees; B Wilcken; G F Hoffmann; P Burgard
Journal:  J Inherit Metab Dis       Date:  2007-01-03       Impact factor: 4.982

Review 5.  Inborn errors of metabolism for the diagnostic radiologist.

Authors:  Chris J Hendriksz
Journal:  Pediatr Radiol       Date:  2008-12-13

6.  'Glutaric aciduria type I--an easily diagnosable and treatable metabolic disorder'.

Authors:  Mahesh Kamate; V D Patil; Vivek Chetal; Virupaxi Hattiholi
Journal:  Indian J Pediatr       Date:  2009-05       Impact factor: 1.967

7.  Glutaric acid administration impairs energy metabolism in midbrain and skeletal muscle of young rats.

Authors:  Gustavo da C Ferreira; Carolina M Viegas; Patrícia F Schuck; Anelise Tonin; César A J Ribeiro; Daniella de M Coelho; Teresa Dalla-Costa; Alexandra Latini; Angela T S Wyse; Clovis M D Wannmacher; Carmen R Vargas; Moacir Wajner
Journal:  Neurochem Res       Date:  2005-09       Impact factor: 3.996

8.  Profile of inborn errors of metabolism in a tertiary care centre PICU.

Authors:  Mahesh Kamate; Vivek Chetal; Vijaylaxmi Kulgod; Vishwanath Patil; Rita Christopher
Journal:  Indian J Pediatr       Date:  2010-02-05       Impact factor: 1.967

9.  Biochemistry and bioenergetics of glutaryl-CoA dehydrogenase deficiency.

Authors:  S W Sauer
Journal:  J Inherit Metab Dis       Date:  2007-09-21       Impact factor: 4.982

Review 10.  Patterns of brain injury in inborn errors of metabolism.

Authors:  Andrea L Gropman
Journal:  Semin Pediatr Neurol       Date:  2012-12       Impact factor: 1.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.